Ulrich Beuers

Research interests

Publications

• A multisociety Delphi consensus statement on new fatty liver disease nomenclature

  Journal of Hepatology · 2023 · https://doi.org/10.1016/j.jhep.2023.06.003

• A multisociety Delphi consensus statement on new fatty liver disease nomenclature

  Hepatology · 2023 · https://doi.org/10.1097/hep.0000000000000520

• EASL Clinical Practice Guidelines on sclerosing cholangitis

  Journal of Hepatology · 2022 · 10.1016/j.jhep.2022.05.011

• Primary sclerosing cholangitis

  The Lancet · 2018 · 10.1016/s0140-6736(18)30300-3

• EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

  Journal of Hepatology · 2017 · https://doi.org/10.1016/j.jhep.2017.03.022

• Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

  Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.02.038

• Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial

  The Lancet · 2017 · 10.1016/s0140-6736(16)31715-9

• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1509840

• Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

  Gastroenterology · 2016 · https://doi.org/10.1053/j.gastro.2016.01.038

• Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

  Nature Genetics · 2016 · https://doi.org/10.1038/ng.3745

• New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

  Journal of Hepatology · 2015 · https://doi.org/10.1016/j.jhep.2015.02.023

• Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1

  Gastroenterology · 2014 · https://doi.org/10.1053/j.gastro.2014.04.022

• Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

  Hepatology · 2013 · 10.1002/hep.26565

• Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

  Journal of Hepatology · 2012 · 10.1016/j.jhep.2011.10.025

• Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions

  Hepatology · 2012 · 10.1002/hep.25748

• Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

  Journal of Hepatology · 2012 · https://doi.org/10.1016/j.jhep.2012.03.031

• A Biliary HCO3 − Umbrella Constitutes A Protective Mechanism Against Bile Acid–Induced Injury in Human Cholangiocytes

  Hepatology · 2011 · 10.1002/hep.24691

• The Biliary HCO3 − Umbrella: A Unifying Hypothesis on Pathogenetic and Therapeutic Aspects of Fibrosing Cholangiopathies

  Hepatology · 2010 · https://doi.org/10.1002/hep.23810

• Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus

  Gastroenterology · 2010 · 10.1053/j.gastro.2010.05.009

• Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

  Gastroenterology · 2009 · 10.1053/j.gastro.2009.11.046

• Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury

  Pharmacogenetics and Genomics · 2007 · 10.1097/01.fpc.0000230418.28091.76

• Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis

  Nature Clinical Practice Gastroenterology &#38 Hepatology · 2006 · 10.1038/ncpgasthep0521

• Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy

  Pharmacogenetics · 2004 · 10.1097/00008571-200402000-00003

• Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited

  Hepatology · 2002 · 10.1053/jhep.2002.36088

• Ursodeoxycholic Acid for Treatment of Primary Sclerosing Cholangitis: A Placebo–Controlled Trial

  Hepatology · 1992 · https://doi.org/10.1002/hep.1840160315

Current projects

No projects listed.